Clinical Trials
| Cancer Type: Breast | |
| Description: A Double-Blind, Randomized Phase 2b Study of Sorafenib Compared to Placebo when Administered in Combination with Chemotherapy for Patients with Locally Advanced or Metastatic Breast Cancer that has Progressed During or After Bevacizumab Therapy |
|
| Entity Approving The Trial: Industry Sponsored |
|
| Phase: IIb | |
| Site-Wide Accrual Goal: 220 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| No related links found. |
 |
 |
|
